The Centre for Cellular and Molecular Platforms (C-CAMP) is launching the 4th edition of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) supported Antimicrobial Resistance (AMR) Quest.
The Quest is a nationwide platform dedicated exclusively to innovations in the AMR domain and aims to identify, reward, and nurture Indian innovators developing solutions to tackle AMR with a specific focus on ESKAPE Pathogens.
The quest presents opportunities for funding and commercialisation of the idea stage, as well as more mature stage innovations.
